Quality of life of patients with Duchenne muscular dystrophy: from adolescence to young men

References

• Brooke MH. A clinician’s view of neuromuscular diseases. 2nd ed. Philadelphia (PA): Williams & Wilkins; 1986.
   Google Scholar
• Hoffman EP, Monaco AP, Feener CC, et al. Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science. 1987;238:347–350.
   PubMed Web of Science ®Google Scholar
• McDonald CM, Henricson EK, Abresch RT, et al. The cooperative international neuromuscular research group Duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used. Muscle Nerve. 2013;48:32–54.
   PubMed Web of Science ®Google Scholar
• Kohler M, Clarenbach CF, Böni L, et al. Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 2005;172:1032–1036.
   PubMed Web of Science ®Google Scholar
• Simon VA, Resende MB, Simon MA, et al. Duchenne muscular dystrophy: quality of life among 95 patients evaluated using the Life Satisfaction Index for Adolescents. Arq Neuropsiquiatr. 2011;69:19–22.
   PubMed Web of Science ®Google Scholar
• Grootenhuis MA, de Boone J, van der Kooi AJ. Living with muscular dystrophy: health related quality of life consequences for children and adults. Health Qual Life Outcomes. 2007;5:31.
   PubMed Web of Science ®Google Scholar
• Baiardini I, Minetti C, Bonifacino S, et al. Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. J Child Neurol. 2011;26:707–713.
   PubMed Web of Science ®Google Scholar
• Bray P, Bundy AC, Ryan MM, et al. Health-related quality of life in boys with Duchenne muscular dystrophy: agreement between parents and their sons. J Child Neurol. 2010;25:1188–1194.
   PubMed Web of Science ®Google Scholar
• Dogba MJ, Rauch F, Douglas E, et al. Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta. Health Qual Life Outcomes. 2014;12:151.
   PubMed Web of Science ®Google Scholar
• Bendixen RM, Senesac C, Lott DJ, et al. Participation and quality of life in children with Duchenne muscular dystrophy using the international classification of functioning, disability, and health. Health Qual Life Outcomes. 2012;10:43.
   PubMed Web of Science ®Google Scholar
• Davis SE, Hynan LS, Limbers CA, et al. The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. J Clin Neuromuscul Dis. 2010;11:97–109.
   PubMedGoogle Scholar
• Ware JE, Jr, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33:AS264–AS279.
   PubMed Web of Science ®Google Scholar
• The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551–558.
   PubMed Web of Science ®Google Scholar
• Huang IC, Wu AW, Frangakis C. Do the SF-36 and WHOQOL-BREF measure the same constructs? Evidence from the Taiwan population*. Qual Life Res. 2006;15:15–24.
   PubMed Web of Science ®Google Scholar
• Ware JE, Jr., Kosinski M, Gandek B, et al. The factor structure of the SF-36 health survey in 10 countries: results from the IQOLA Project. International quality of life assessment. J Clin Epidemiol. 1998;51:1159–1165.
   PubMed Web of Science ®Google Scholar
• Skevington SM, Lotfy M, WHOQOL Group, et al. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13:299–310.
   PubMed Web of Science ®Google Scholar
• Lue YJ, Su CY, Yang RC, et al. Development and validation of a muscular dystrophy-specific functional rating scale. Clin Rehabil. 2006;20:804–817.
   PubMed Web of Science ®Google Scholar
• Jennekens FGI, Kate LP, de Visser M, et al. Duchenne and Becker muscular dystrophies. In: Emery AEH, editor. Diagnostic criteria for neuromuscular disorders. 1st ed. Baarn (Netherlands): The Netherlands: European Neuromuscular Centre; 1994. p. 9–13.
   Google Scholar
• Brooke MH, Griggs RC, Mendell JR, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981;4:186–197.
   PubMed Web of Science ®Google Scholar
• Vignos PJ, Archibald KC. Maintenance of ambulation in childhood muscular dystrophy. J Chronic Dis. 1960;12:273–290.
   PubMedGoogle Scholar
• Lu JFR, Tseng HM, Tsai YJ. Assessment of health-related quality of life in Taiwan (I): development and psychometric testing of SF-36 Taiwan version. Taiwan J Public Health. 2003;22:501–511.
   Google Scholar
• Yao G, Chung CW, Yu CF, et al. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc. 2002;101:342–351.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–1134.
   PubMed Web of Science ®Google Scholar
• Ware JE, Snow KK, Kosinski M, et al. SF-36 health survey: manual and interpretation guide. Lincoln (RI): QualityMetric Incorporated; 1993.
   Google Scholar
• Tseng HM, Lu JFR, Tsai YJ. Assessment of health-related quality of life in Taiwan (II): norming and validation of SF-36 Taiwan version. Taiwan J Public Health. 2003;22:512–518.
   Google Scholar
• Yao KP. Development of the WHOQOL-BREF Taiwan version: user guide. 2nd version. Taipei: WHOQOL-BREF-Taiwan Version Study Group; 2004.
   Google Scholar
• Connolly AM, Malkus EC, Mendell JR, et al. Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy. Muscle Nerve. 2015;51:522–532.
   PubMed Web of Science ®Google Scholar
• Cohen J. A power primer. Psychol Bull. 1992;112:266–269.
   Web of Science ®Google Scholar
• Pehler SR, Craft-Rosenberg M. Longing: the lived experience of spirituality in adolescents with Duchenne muscular dystrophy. J Pediatr Nurs. 2009;24:481–494.
   PubMedGoogle Scholar
• Abbott D, Carpenter J, Bushby K. Transition to adulthood for young men with Duchenne muscular dystrophy: research from the UK. Neuromuscul Disord. 2012;22:445–446.
   PubMed Web of Science ®Google Scholar
• Schrans DG, Abbott D, Peay HL, et al. Transition in Duchenne muscular dystrophy: an expert meeting report and description of transition needs in an emergent patient population: parent project muscular dystrophy transition expert meeting 17–18 June 2011, Amsterdam, The Netherlands. Neuromuscul Disord. 2013;23:283–286.
   PubMed Web of Science ®Google Scholar
• Hinton VJ, Nereo NE, Fee RJ, et al. Social behavior problems in boys with Duchenne muscular dystrophy. J Dev Behav Pediatr. 2006;27:470–476.
   PubMed Web of Science ®Google Scholar
• Bushby K, Finkel R Birnkrant DJ, DMD Care Considerations Working Group, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77–93.
   PubMed Web of Science ®Google Scholar
• Fee RJ, Hinton VJ. Resilience in children diagnosed with a chronic neuromuscular disorder. J Dev Behav Pediatr. 2011;32:644–650.
   PubMed Web of Science ®Google Scholar
• Zebracki K, Drotar D. Pain and activity limitations in children with Duchenne or Becker muscular dystrophy. Dev Med Child Neurol. 2008;50:546–552.
   PubMed Web of Science ®Google Scholar
• Pangalila RF, van den Bos GA, Bartels B, et al. Prevalence of fatigue, pain, and affective disorders in adults with Duchenne muscular dystrophy and their associations with quality of life. Arch Phys Med Rehabil. 2015;96:1242–1247.
   PubMed Web of Science ®Google Scholar